A Single-center, Open-label, Phase I Drug-drug Interaction Clinical Study to Investigate the Effect of SKLB1028 on the Pharmacokinetics of Midazolam in Healthy Subjects
Latest Information Update: 12 Oct 2021
At a glance
- Drugs Midazolam (Primary) ; SKLB 1028 (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacokinetics
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 12 Oct 2021 New trial record